Vicarious Surgical (RBOT) Operating Income (2020 - 2025)
Vicarious Surgical's (RBOT) quarterly Operating Income came in at -$11.5 million in Q3 2025, up 35.21% year-on-year from -$8.5 million in Q3 2024, and up 14.91% on a QoQ basis from -$13.5 million in Q2 2025.
Vicarious Surgical (RBOT) Operating Income (2020 - 2025) Analysis & Trends
Vicarious Surgical (RBOT) has 6 years of Operating Income data on file, last reported at -$11.5 million in Q3 2025.
- On a quarterly basis, Operating Income rose 35.21% year-over-year to -$11.5 million in Q3 2025; TTM through Sep 2025 was -$55.7 million, a 16.94% increase from a year earlier, with the FY2024 full-year figure at -$66.6 million, up 17.49% from the prior year.
- Operating Income for Q3 2025 stood at -$11.5 million, up from -$13.5 million in the prior quarter.
- Over the last five years, Operating Income for RBOT reached as high as -$5.2 million in Q1 2021 and fell as low as -$22.3 million in Q1 2023.
- Historically, Operating Income has averaged -$16.1 million across 5 years, with a median of -$17.7 million in 2024.
- Across the five-year window, Operating Income tumbled 24660.34% in 2021 and soared 35.21% in 2025, its largest moves.
- Year by year, Operating Income stood at -$17.8 million in 2021, then declined by 15.66% to -$20.6 million in 2022, then climbed by 24.59% to -$15.5 million in 2023, then rose by 3.62% to -$15.0 million in 2024, then rose by 23.2% to -$11.5 million in 2025.
- Per Business Quant data, the three most recent Operating Income figures were -$11.5 million in Q3 2025, -$13.5 million in Q2 2025, and -$15.7 million in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.35 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 936.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.87 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.10 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 477.60 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 255.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 282.15 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 515.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Vicarious Surgical | 654,984.55 | -9.14 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -11.50 Mn |
| Jun 30, 2025 | -13.52 Mn |
| Mar 31, 2025 | -15.75 Mn |
| Dec 31, 2024 | -14.98 Mn |
| Sep 30, 2024 | -17.76 Mn |
| Jun 30, 2024 | -17.71 Mn |
| Mar 31, 2024 | -16.11 Mn |
| Dec 31, 2023 | -15.54 Mn |
| Sep 30, 2023 | -21.35 Mn |
| Jun 30, 2023 | -21.46 Mn |
| Mar 31, 2023 | -22.32 Mn |
| Dec 31, 2022 | -20.61 Mn |
| Sep 30, 2022 | -22.16 Mn |
| Jun 30, 2022 | -19.13 Mn |
| Mar 31, 2022 | -18.18 Mn |
| Dec 31, 2021 | -17.82 Mn |
| Sep 30, 2021 | -8.56 Mn |
| Jun 30, 2021 | -6.61 Mn |
| Mar 31, 2021 | -5.23 Mn |
| Dec 31, 2020 | -3.78 Mn |